Cris Kamperschroer Selected Research

Cris Kamperschroer Research Topics

12	Neoplasms (Cancer) 04/2024 - 10/2012
5	Infections 12/2023 - 07/2002
3	Cytokine Release Syndrome 04/2024 - 11/2019
3	Human Influenza (Influenza) 10/2010 - 06/2006
2	Lymphoma (Lymphomas) 01/2016 - 01/2012
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2012 - 07/2006
1	Anemia 10/2023
1	Hypothermia 10/2023
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 10/2023
1	Hypophosphatemia 01/2022
1	Hypersensitivity (Allergy) 02/2021
1	Colonic Neoplasms (Colon Cancer) 10/2020
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Multiple Myeloma 11/2019
1	Stillbirth 06/2015
1	Virus Diseases (Viral Diseases) 01/2014
1	Bacterial Infections (Bacterial Infection) 01/2009
1	Wasting Syndrome (Wasting Disease) 07/2002

5	CytokinesIBA 02/2021 - 07/2002
4	AntigensIBA 12/2020 - 10/2010
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 06/2006
3	Cadherins (E-Cadherin)IBA 01/2022 - 01/2019
2	PF-06671008IBA 01/2022 - 01/2019
2	VaccinesIBA 01/2009 - 06/2006
2	Signaling Lymphocytic Activation Molecule Associated ProteinIBA 10/2006 - 07/2006
2	Antiviral Agents (Antivirals)IBA 10/2006 - 07/2002
1	Histocompatibility Antigens Class IIBA 12/2023
1	Peptides (Polypeptides)IBA 12/2023
1	AutoantibodiesIBA 10/2023
1	Cell Adhesion MoleculesIBA 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 02/2021
1	Enterotoxin ReceptorsIBA 01/2020
1	B-Cell Maturation AntigenIBA 11/2019
1	crisamicin AIBA 11/2019
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 11/2019
1	trans-sodium crocetinate (crocetin)IBA 01/2019
1	tanezumabIBA 06/2015
1	Monoclonal AntibodiesIBA 10/2012
1	utomilumabIBA 10/2012
1	Immunomodulating AgentsIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	Immunoglobulin G (IgG)IBA 10/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2002
1	Interleukin-1 (Interleukin 1)IBA 07/2002
1	Cytokine Receptors (Cytokine Receptor)IBA 07/2002
1	Interleukin-6 (Interleukin 6)IBA 07/2002

5	Therapeutics 04/2024 - 10/2012
2	Immunotherapy 10/2020 - 01/2020